Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Alcohol Use Disorder Outcomes A national cohort study in Denmark of 38,454 individuals showed that GLP-1 medications were associated with a reduced risk of alcohol-related outcomes after three months of treatment, which included fewer hospitalizations, registered alcohol use disorder treatment, and purchase of medications to manage alcohol withdrawal (Wium-Andersen et al., 2022)
We typically recommend a series of two treatments for initial results followed by one to two treatments a year to maintain them
This is especially important during a clinical trial, as trial data helps form a clearer picture of a medications safety profile
Understanding your genetic predispositions helps clinicians determine whether slower dose escalation, a different compound like tirzepatide, or supportive interventions will optimize your results
The central question is therefore not whether glucagon raises glucose under physiologic conditions
Phase 4: Maintenance (Week 60+) What to expect: Weight stabilization and long-term management
